Literature DB >> 24100035

Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect.

An-Hoa Giang1, Tamara Raymond, Paul Brookes, Karen de Mesy Bentley, Edward Schwarz, Regis O'Keefe, Roman Eliseev.   

Abstract

Metabolic reprogramming in cancer is manifested by persistent aerobic glycolysis and suppression of mitochondrial function and is known as the Warburg effect. The Warburg effect contributes to cancer progression and is considered to be a promising therapeutic target. Understanding the mechanisms used by cancer cells to suppress their mitochondria may lead to development of new approaches to reverse metabolic reprogramming. We have evaluated mitochondrial function and morphology in poorly respiring LM7 and 143B osteosarcoma (OS) cell lines showing the Warburg effect in comparison with actively respiring Saos2 and HOS OS cells and noncancerous osteoblastic hFOB cells. In LM7 and 143B cells, we detected markers of the mitochondrial permeability transition (MPT), such as mitochondrial swelling, depolarization, and membrane permeabilization. In addition, we detected mitochondrial swelling in human OS xenografts in mice and archival human OS specimens using electron microscopy. The MPT inhibitor sanglifehrin A reversed MPT markers and increased respiration in LM7 and 143B cells. Our data suggest that the MPT may play a role in suppression of mitochondrial function, contributing to the Warburg effect in cancer.

Entities:  

Keywords:  Cancer; Cyclophilin D; Glycolysis; Mitochondria; Mitochondrial Permeability Transition; Osteosarcoma; Warburg Effect

Mesh:

Year:  2013        PMID: 24100035      PMCID: PMC3829176          DOI: 10.1074/jbc.M113.507129

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 2.  VDAC inhibition by tubulin and its physiological implications.

Authors:  Tatiana K Rostovtseva; Sergey M Bezrukov
Journal:  Biochim Biophys Acta       Date:  2011-11-09

Review 3.  Learning from oncocytic tumors: Why choose inefficient mitochondria?

Authors:  Giuseppe Gasparre; Giovanni Romeo; Michela Rugolo; Anna Maria Porcelli
Journal:  Biochim Biophys Acta       Date:  2010-08-21

4.  Mitochondrial dysfunction in cancer cells due to aberrant mitochondrial replication.

Authors:  Yuriy Shapovalov; David Hoffman; Daniel Zuch; Karen L de Mesy Bentley; Roman A Eliseev
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

Review 5.  Imaging cycling tumor hypoxia.

Authors:  Shingo Matsumoto; Hironobu Yasui; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

Review 6.  Targeting mitochondria as a therapeutic target in cancer.

Authors:  Charles E Wenner
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 7.  Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis.

Authors:  Andrea Rasola; Paolo Bernardi
Journal:  Cell Calcium       Date:  2011-05-23       Impact factor: 6.817

Review 8.  Ischemia-reperfusion injury in the aged heart: role of mitochondria.

Authors:  Edward J Lesnefsky; Charles L Hoppel
Journal:  Arch Biochem Biophys       Date:  2003-12-15       Impact factor: 4.013

9.  Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells: regulation by free tubulin and erastin.

Authors:  Eduardo N Maldonado; Kely L Sheldon; David N DeHart; Jyoti Patnaik; Yefim Manevich; Danyelle M Townsend; Sergey M Bezrukov; Tatiana K Rostovtseva; John J Lemasters
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

Review 10.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  20 in total

Review 1.  Causes of genome instability: the effect of low dose chemical exposures in modern society.

Authors:  Sabine A S Langie; Gudrun Koppen; Daniel Desaulniers; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Amaya Azqueta; William H Bisson; Dustin G Brown; Gunnar Brunborg; Amelia K Charles; Tao Chen; Annamaria Colacci; Firouz Darroudi; Stefano Forte; Laetitia Gonzalez; Roslida A Hamid; Lisbeth E Knudsen; Luc Leyns; Adela Lopez de Cerain Salsamendi; Lorenzo Memeo; Chiara Mondello; Carmel Mothersill; Ann-Karin Olsen; Sofia Pavanello; Jayadev Raju; Emilio Rojas; Rabindra Roy; Elizabeth P Ryan; Patricia Ostrosky-Wegman; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Frederik J Van Schooten; Mahara Valverde; Jordan Woodrick; Luoping Zhang; Nik van Larebeke; Micheline Kirsch-Volders; Andrew R Collins
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

2.  Energy Metabolism in Mesenchymal Stem Cells During Osteogenic Differentiation.

Authors:  Laura C Shum; Noelle S White; Bradley N Mills; Karen L de Mesy Bentley; Roman A Eliseev
Journal:  Stem Cells Dev       Date:  2015-12-10       Impact factor: 3.272

3.  Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity.

Authors:  Erika Rodrigues-Silva; Edilene S Siqueira-Santos; Juliana S Ruas; Raffaela S Ignarro; Tiago R Figueira; Fábio Rogério; Roger F Castilho
Journal:  J Neurooncol       Date:  2017-05-24       Impact factor: 4.130

4.  Transcriptional regulation of cyclophilin D by BMP/Smad signaling and its role in osteogenic differentiation.

Authors:  Rubens Sautchuk; Brianna H Kalicharan; Katherine Escalera-Rivera; Jennifer H Jonason; George A Porter; Hani A Awad; Roman A Eliseev
Journal:  Elife       Date:  2022-05-30       Impact factor: 8.713

Review 5.  Cyclophilin D: Guardian or Executioner for Tumor Cells?

Authors:  Ling Zhang; Yi Liu; Rou Zhou; Baoyu He; Wenjun Wang; Bin Zhang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

6.  A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.

Authors:  Daniel L Holmes; Daniel T Vogt; Michael Lagunoff
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

7.  Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks.

Authors:  Rui Hu; Shan Chen; Jianxin Yan
Journal:  J Orthop Surg Res       Date:  2021-05-07       Impact factor: 2.359

8.  SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway.

Authors:  Shu-Jie Zhao; Yi-Fei Shen; Qing Li; Yun-Jie He; Yun-Kun Zhang; Li-Peng Hu; Yu-Qing Jiang; Nan-Wei Xu; Yu-Ji Wang; Jun Li; Ya-Hui Wang; Fei Liu; Rong Zhang; Guo-Yong Yin; Jin-Hai Tang; Dong Zhou; Zhi-Gang Zhang
Journal:  Cell Death Dis       Date:  2018-03-09       Impact factor: 8.469

9.  T-cells produce acidic niches in lymph nodes to suppress their own effector functions.

Authors:  Hao Wu; Veronica Estrella; Matthew Beatty; Dominique Abrahams; Asmaa El-Kenawi; Shonagh Russell; Arig Ibrahim-Hashim; Dario Livio Longo; Yana K Reshetnyak; Anna Moshnikova; Oleg A Andreev; Kimberly Luddy; Mehdi Damaghi; Krithika Kodumudi; Smitha R Pillai; Pedro Enriquez-Navas; Shari Pilon-Thomas; Pawel Swietach; Robert J Gillies
Journal:  Nat Commun       Date:  2020-08-17       Impact factor: 14.919

10.  c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells.

Authors:  Ander Abarrategi; Stefano Gambera; Arantzazu Alfranca; Miguel A Rodriguez-Milla; Raquel Perez-Tavarez; Kevin Rouault-Pierre; Alexander Waclawiczek; Probir Chakravarty; Francisca Mulero; César Trigueros; Samuel Navarro; Dominique Bonnet; Javier García-Castro
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.